Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerlach

Showing results (281-290 of 352) with videos related to

Pageof 36
Sort By:
Antimicrobial Agents and Chemotherapy|July 1, 1980
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancerB G Campling, L C Young, K A Baer, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolatesS A Marshall, R N Jones, P R Murray, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 6, 2000
Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAs in lung tumor cells and normal and malignant lung tissueS E Mirski, T Voskoglou-Nomikos, L C Young, et al.
BMC Neurology|March 10, 2012
Deterioration of Parkinson's disease during hospitalization: survey of 684 patientsOliver H H Gerlach, Martijn P G Broen, Peter H M F van Domburg, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenemR N Jones, K E Aldridge, S D Allen, et al.
Pageof 36

Showing results (281-290 of 352) with videos related to

Sort By:
Pageof 36
Antimicrobial Agents and Chemotherapy|July 1, 1980
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1997
Expression of the MRP and MDR1 multidrug resistance genes in small cell lung cancerB G Campling, L C Young, K A Baer, et al.
Journal of Clinical Microbiology|March 1, 1992
Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1993
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolatesS A Marshall, R N Jones, P R Murray, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 6, 2000
Simultaneous quantitation of topoisomerase II alpha and beta isoform mRNAs in lung tumor cells and normal and malignant lung tissueS E Mirski, T Voskoglou-Nomikos, L C Young, et al.
BMC Neurology|March 10, 2012
Deterioration of Parkinson's disease during hospitalization: survey of 684 patientsOliver H H Gerlach, Martijn P G Broen, Peter H M F van Domburg, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenemR N Jones, K E Aldridge, S D Allen, et al.
Pageof 36